Daniel Delorme

This inventor holds 38 USPTO granted patents and 3 published patent applications, plus 5 CIPO patents and 8 EPO patents, primarily in Pharmaceutical Compositions. Top assignees: Methylgene, Inc., Merck Frosst Canada, Inc., Astrazeneca Canada Inc.. Active years: 1991-2021.

USPTO Granted Patents = 38 (Patent Applications = 3)

% Patents Active = 76.3

CIPO Patents = 5

EPO Patents = 8 (Patent Applications = 1)

Average Co-Inventor Count = 4.6

ph-index = 13

Forward Citations = 545(Granted Patents)

Location History:

Quebec, CA (1991 - 2007)
St. Lazare, CA (1992 - 2007)
St-Lazare, CA (1994 - 2019)
Saint-Lazare, CA (2011 - 2021)

Company Filing History:

Merck Frosst Canada, Inc.

patents

6 out of 14

Astrazeneca Canada Inc.

Bhi Limited Partnership

Years Active: 1991-2021

Loading Chart...

Areas of Expertise:

3-Amino-1-Propanesulfonic Acid

Histone Deacetylase Inhibitors

Amyloid-Related Diseases

Analgesic Compounds

Beta-Lactamase Inhibitors

Pain Management

Leukotriene Biosynthesis

Substituted Urea Compounds

Heteroarylnaphthalene

Dibenzoheterocyclic Hydroxamic Acids

Thioindoles

Biaryl Compounds

38 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11020360 - Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid (2021-06-01),

2. 10857109 - Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid (2020-12-08),

3. 10238611 - Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid (2019-03-26),

4. 9499480 - Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid (2016-11-22),

5. 8835654 - Method and compositions for treating amyloid-related diseases (2014-09-16),

6. 8748656 - Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid (2014-06-10),

7. RE43343 - Inhibitors of histone deacetylase (2012-04-30),

8. 8088805 - Inhibitors of histone deacetylase (2012-01-03),

9. 8044100 - Methods and compositions for treating amyloid-related diseases (2011-10-25),

10. 7868204 - Inhibitors of histone deacetylase (2011-01-11),

11. 7838520 - Inhibitors of histone deacetylase (2010-11-23),

12. 7595343 - Inhibitors of histone deacetylase (2009-09-29),

13. 7312336 - Compounds with analgesic effect (2007-12-25),

14. 7288567 - Inhibitors of histone deacetylase (2007-10-30),

15. 7282608 - Inhibitors of histone deacetylase (2007-10-16),

Title: The Innovative Journey of Daniel Delorme

Introduction: Daniel Delorme, a talented inventor hailing from St-Lazare, CA, has made significant contributions to the world of technology through his groundbreaking inventions and patents.

Latest Patents: Daniel Delorme's latest patents include a revolutionary smart home device that integrates artificial intelligence to enhance security measures and a cutting-edge medical device designed to improve patient care and treatment outcomes.

Career Highlights: Throughout his illustrious career, Daniel Delorme has been recognized for his innovative spirit and dedication to pushing the boundaries of technology. His inventions have not only improved the quality of life for many but have also paved the way for future advancements in various industries.

Collaborations: Daniel Delorme has collaborated with leading tech companies and research institutions to bring his inventions to life. His ability to work seamlessly with teams of experts has been instrumental in the success of his projects.

Conclusion: In conclusion, Daniel Delorme's passion for innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of inventors. His contributions continue to inspire and shape the future of technology.